ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
Е. О. Таратухин
Abstract
Open-access reader
Е. О. Таратухин
Abstract
Open-access reader
This literature review focuses on the angiotensin II receptor antagonists as one of the new and promising classes of antihypertensive medications. Apart from their antihypertensive activity, these agents possess a number of other beneficial effects. The results of multiple studies, including large multi-centre clinical trials, are presented for olmesartan, an angiotensin receptor antagonist with additional beneficial properties.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This literature review focuses on the angiotensin II receptor antagonists as one of the new and promising classes of antihypertensive medications. Apart from their antihypertensive activity, these agents possess a number of other beneficial effects. The results of multiple studies, including large multi-centre clinical trials, are presented for olmesartan, an angiotensin receptor antagonist with additional beneficial properties.
Key concepts: Olmesartan, Medicine, Pharmacology, Angiotensin receptor, Antagonist, Angiotensin II, Angiotensin II receptor antagonist, Angiotensin II receptor type 1